Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - IMS Health Holdings, Inc. | a51069439ex99_1.htm |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March
27, 2015
IMS Health Holdings, Inc.
(Exact
name of registrant as specified in its charter)
| Delaware | 001-36381 | 27-1335689 | ||
| (State or other jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
| of incorporation) | Identification No.) |
83 Wooster Heights Road
Danbury, CT 06810
(Address
of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (203) 448-4600
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
|
|
⃞ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
⃞ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
⃞ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
⃞ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 27, 2015 the Board of Directors of IMS Health Holdings, Inc. (the “Company”) increased the size of the Board from seven to eight members and elected Karen Katen as director of the Company upon the recommendation of the Nominating and Corporate Governance Committee. Ms. Katen will serve as a Class II director, which class will stand for re-election at the 2016 annual meeting of stockholders. The Board of Directors also appointed Ms. Katen to serve on the Audit Committee of the Board. Ms. Katen will participate in the Company’s standard non-employee director compensation program described in the Company’s 2014 proxy statement, filed with the Securities and Exchange Commission on March 3, 2015. The Company’s press release announcing Ms. Katen’s election is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
|
Exhibit Number |
Description |
|
| 99.1 | Press release, dated March 30, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
IMS Health Holdings, Inc. |
||||
|
(Registrant) |
||||
|
Date: March 30, 2015 |
By: | /s/ Ronald E. Bruehlman | ||
|
Name: |
Ronald E. Bruehlman |
|||
|
Title: |
Senior Vice President and Chief Financial Officer |
|||
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
| 99.1 |
Press release, dated March 30, 2015 |